A
UTHR icon

AlphaQuest’s United Therapeutics UTHR Stock Holding History

AlphaQuest’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,246
Closed -$607K – 1999
2025
Q4 		$607K Buy
1,246
+811
+186% +$378K 0.03% 685
2025
Q3 		$182K Sell
435
-720
-62% -$242K 0.01% 1458
2025
Q2 		$332K Sell
1,155
-519
-31% -$155K 0.03% 827
2025
Q1 		$516K Sell
1,674
-638
-28% -$219K 0.06% 513
2024
Q4 		$816K Buy
2,312
+1,063
+85% +$391K 0.11% 303
2024
Q3 		$448K Buy
1,249
+970
+348% +$328K 0.04% 703
2024
Q2 		$88.9K Sell
279
-125
-31% -$33.1K 0.01% 958
2024
Q1 		$92.8K Sell
404
-3,096
-88% -$699K 0.02% 831
2023
Q4 		$770K Buy
+3,500
New +$807K 0.16% 213

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

AlphaQuest's UTHR Position: Q1 2026 in Review

AlphaQuest sold out of United Therapeutics (UTHR) in Q1 2026, closing a stake of 1,246 shares — an estimated $607K sold.

AlphaQuest first reported a position in UTHR in Q4 2023 and held it in 9 quarters. The position peaked at $816K in Q4 2024. 854 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • AlphaQuest reported no remaining United Therapeutics position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 1,246 United Therapeutics shares in Q1 2026, an estimated $607K.
  • AlphaQuest first reported a position in United Therapeutics in Q4 2023 and held it in 9 quarters.
  • AlphaQuest's United Therapeutics position peaked at $816K in Q4 2024.
  • 854 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.